Dysfunctional Coagulation in COVID-19: From Cell to Bedside Jie WangArdan M. SagunerGuoliang Li Commentary 05 June 2020 Pages: 3033 - 3039
A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible? Jie ZhangJunlong LiEric Wu Commentary Open access 10 June 2020 Pages: 3040 - 3058
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review Hope S. RugoIra JacobsGabriel G. Malouf Review Open access 22 May 2020 Pages: 3059 - 3082
Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence Ines LakbarJan J. De WaeleMarc Leone Review Open access 27 May 2020 Pages: 3083 - 3096
Diagnosis and Management of Hypothyroidism in Gulf Cooperation Council (GCC) Countries Ali S. AlzahraniMourad Al MouradEslam Abdelhamid Review Open access 01 June 2020 Pages: 3097 - 3111
Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative Review Andrés Coca-PelazJatin P. ShahAlfio Ferlito Review Open access 01 June 2020 Pages: 3112 - 3128
Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study Shaum M. KabadiAimee NearChakkarin Burudpakdee Original Research 12 May 2020 Pages: 3129 - 3148
Correction to: Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study Shaum M. KabadiAimee NearChakkarin Burudpakdee Correction 13 June 2020 Pages: 3149 - 3149
Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study Sicong MaZaixin JiangYaling Han Original Research 16 May 2020 Pages: 3150 - 3161
Correction to: Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study Sicong MaZaixin JiangYaling Han Correction 09 June 2020 Pages: 3162 - 3162
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy James BowenRina MehtaMachaon Bonafede Original Research Open access 20 May 2020 Pages: 3163 - 3177
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy Maria Laura CanaleAndrea CameriniNicola Maurea Original Research Open access 20 May 2020 Pages: 3178 - 3184
Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma Dazhuang GeZhiwen LuoJianqiang Cai Original Research 20 May 2020 Pages: 3185 - 3205
Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study Yuying ZhangZhancong OuJiaqi Chen Original Research 20 May 2020 Pages: 3206 - 3222
Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis Michele De MariaMarco CoassinLuigi Fontana Original Research 21 May 2020 Pages: 3223 - 3233
Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients Shuichi TsuruokaTakamasa EndoNaoto Hashimoto Original Research Open access 21 May 2020 Pages: 3234 - 3245
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach Wim A. WuytsSpyridon PapirisStéphane Soulard Original Research Open access 22 May 2020 Pages: 3246 - 3264
Best Practice Approach to Successful Conversion of Fosaprepitant to Aprepitant IV in a Large Multisite Community Oncology Infusion Center: A Retrospective Analysis Derek BurnsJulianna KulaMatthew Ornelas Original Research Open access 23 May 2020 Pages: 3265 - 3277
Prevalence and Management Challenges in Central Post-Stroke Neuropathic Pain: A Systematic Review and Meta-analysis Andreas LiampasNikolaos VelidakisPanagiotis Zis Original Research Open access 23 May 2020 Pages: 3278 - 3291
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA Amy L. OlsonToby M. MaherLou De Loureiro Original Research Open access 21 May 2020 Pages: 3292 - 3298
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3–11 Years with Hepatitis C Genotype 1a Philip RosenthalMichael R. NarkewiczDaniel H. Leung Original Research Open access 25 May 2020 Pages: 3299 - 3310
Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study Yasushi GotoNobuyuki YamamotoYuichiro Ohe Original Research 29 May 2020 Pages: 3311 - 3323
Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan Nakao IwataAtaru InagakiSakiko Yamada Original Research Open access 04 June 2020 Pages: 3324 - 3336
Troponin Levels Relate to CRP Concentrations in Patients With NAFLD on Maintenance Haemodialysis: A Retrospective Study Domenico CaponeMauro VinciguerraGiovanni Tarantino Original Research Open access 08 June 2020 Pages: 3337 - 3347
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland Erkki SoiniOuti VirtanenAurelie Millier Original Research Open access 09 June 2020 Pages: 3348 - 3369
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta®): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers Shahrzad MoosaviTroy BoremaHsuan-Ming Yao Original Research Open access 10 June 2020 Pages: 3370 - 3391
Real-World Treatment Patterns and Outcomes in Patients Receiving Second-Line Therapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma Pranav AbrahamJoe GricarVeena Shankaran Original Research Open access 12 June 2020 Pages: 3392 - 3403
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study—Asian Subgroup Analysis Shang-Yi HuangSung-Soo YoonChang-Ki Min Brief Report Open access 10 June 2020 Pages: 3404 - 3416
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program William J. SandbornSeverine VermeireThe Etrolizumab Global Steering Committee Study Protocol Open access 22 May 2020 Pages: 3417 - 3431
Correction to: Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets José-Vicente TorregrosaJaime Sánchez del PozoManuel Muñoz Torres Correction 23 May 2020 Pages: 3432 - 3432
